NanHua Bio-medicine Co., Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 104.11 million compared to CNY 67.4 million a year ago. Revenue was CNY 109.78 million compared to CNY 67.4 million a year ago. Net income was CNY 2.17 million compared to net loss of CNY 6.3 million a year ago. Basic earnings per share from continuing operations was CNY 0.007 compared to basic loss per share from continuing operations of CNY 0.0202 a year ago. Diluted earnings per share from continuing operations was CNY 0.007 compared to diluted loss per share from continuing operations of CNY 0.0202 a year ago.